Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial

    July 2021 in “EClinicalMedicine

    We don't know much about this study yet.

    We're trying to become the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    View this study on thelancet.com →

    Cited in this study

    Related